Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accurate Prediction of Conversion to Alzheimer’s Disease using Imaging, Genetic, and Neuropsychological Biomarkers

23 Nov 2015

Abstract excerpt

A variety of imaging, neuropsychological, and genetic biomarkers have been suggested as potential biomarkers for the identification of mild cognitive impairment (MCI) in patients who later develop Alzheimer's disease (AD). Here, we systematically evaluated the most promising combinations of these biomarkers regarding discrimination between stable and converter MCI and reflection of disease staging. Alzheimer's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Neurological Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26599054
DOI: 10.3233/jad-150570

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accurate Prediction of Conversion to Alzheimer’s Disease using Imaging, Genetic, and Neuropsychological BiomarkersPMID 26599054Read ↗

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.Semantic proximity Read ↗

Genetic, structural and functional imaging biomarkers for early detection of conversion from MCI to AD.Semantic proximity Read ↗

Predicting 24-Month MCI-to-Alzheimer’s Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic TestingSemantic proximity Read ↗

A Novel Ensemble-Based Machine Learning Algorithm To Predict The Conversion From Mild Cognitive Impairment To Alzheimer’s Disease Using Socio-demographic Characteristics, Clinical Information And Neuropsychological MeasuresSemantic proximity Read ↗

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read ↗

Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.Semantic proximity Read ↗

Identification of Mild Cognitive Impairment Subtypes Predicting Conversion to Alzheimer’s Disease Using a Heterogeneous Mixture LearningSemantic proximity Read ↗

Predicting conversion to Alzheimer’s Disease in individuals with Mild Cognitive Impairment using clinically transferable featuresSemantic proximity Read ↗

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms.Semantic proximity Read ↗

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.Semantic proximity Read ↗

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's diseaseSemantic proximity Read ↗

Risk factors and predictive models in the progression from MCI to Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.